3-186666198-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000412.5(HRG):c.167C>T(p.Ala56Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00139 in 1,613,882 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000412.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HRG | NM_000412.5 | c.167C>T | p.Ala56Val | missense_variant | 1/7 | ENST00000232003.5 | NP_000403.1 | |
HRG-AS1 | XR_924801.3 | n.291-14327G>A | intron_variant, non_coding_transcript_variant | |||||
HRG | XM_005247415.5 | c.167C>T | p.Ala56Val | missense_variant | 1/7 | XP_005247472.1 | ||
HRG-AS1 | XR_001741059.2 | n.291-14327G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HRG | ENST00000232003.5 | c.167C>T | p.Ala56Val | missense_variant | 1/7 | 1 | NM_000412.5 | ENSP00000232003 | P1 | |
HRG-AS1 | ENST00000630178.2 | n.238+52269G>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000802 AC: 122AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000729 AC: 183AN: 251156Hom.: 0 AF XY: 0.000634 AC XY: 86AN XY: 135742
GnomAD4 exome AF: 0.00145 AC: 2126AN: 1461586Hom.: 3 Cov.: 31 AF XY: 0.00138 AC XY: 1004AN XY: 727106
GnomAD4 genome AF: 0.000801 AC: 122AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000658 AC XY: 49AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 28, 2024 | Variant summary: HRG c.167C>T (p.Ala56Val) results in a non-conservative amino acid change located in the Cystatin domain (IPR000010) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00073 in 251156 control chromosomes. c.167C>T has been reported in the literature in individual(s) affected with pulmonary arterial hypertension, without strong evidence for causality (Song_2016). These report(s) do not provide unequivocal conclusions about association of the variant with Hereditary Thrombophilia Due To Congenital Histidine-Rich (poly-L) Glycoprotein Deficiency. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 27613157). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at